Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed  Series A Financing to Advance its KnotBody ...

Roche (OTCQX:RHHBY) is looking to boost its presence in the booming weight-loss market through an exclusive collaboration and ...

Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with Boehringer Ingelheim to accelerate ...

Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...

This study makes the fundamental discovery of the first natural animal rhodopsin that uses a chloride ion instead of an amino acid side chain as a counterion. Using a combination of biochemical and ...

G protein-coupled receptors (GPCRs) are integral membrane proteins with seven membrane-spanning helices. Upon binding to a ligand – which can range from small molecules like cyclic AMP to ...

Each share class—typically labeled A, B, or C—comes with its own combination of upfront costs, ongoing fees, and investment minimums. Whether you're just starting to invest or you're managing ...

The way they're working as small molecules go, they're actually rather complex, and they have to really bind into a big, flexible pocket on a class of receptor called the G protein-coupled receptor.

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...